1. Home
  2. BRAI vs RAPP Comparison

BRAI vs RAPP Comparison

Compare BRAI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRAI

Braiin Limited Common Stock

N/A

Current Price

$7.21

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$37.77

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAI
RAPP
Founded
N/A
2022
Country
Australia
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
BRAI
RAPP
Price
$7.21
$37.77
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$48.50
AVG Volume (30 Days)
14.9K
329.7K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.62
$7.73
52 Week High
$32.32
$42.27

Technical Indicators

Market Signals
Indicator
BRAI
RAPP
Relative Strength Index (RSI) 29.18 58.39
Support Level $6.62 $25.48
Resistance Level $8.27 $41.59
Average True Range (ATR) 1.28 2.18
MACD -1.10 0.06
Stochastic Oscillator 3.65 59.30

Price Performance

Historical Comparison
BRAI
RAPP

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: